Skip to Content
Merck
  • Predicting the carcinogenicity of the aromatic amine derivatives tested in the second UKEMS Collaborative Study.

Predicting the carcinogenicity of the aromatic amine derivatives tested in the second UKEMS Collaborative Study.

Mutagenesis (1986-03-01)
F K Ennever, H S Rosenkranz
ABSTRACT

The carcinogenicity prediction and battery selection (CPBS) procedure was used to analyze the short-term in vitro and in vivo genotoxicity results obtained during the Second UKEMS Collaborative Study. In accordance with preliminary animal bioassay results, CPBS predicted correctly the carcinogenicity of benzidine, 4,4"-diaminoterphenyl and 4-dimethylaminoazobenzene. CPBS predicted the non-carcinogenicity of 4-cyanodimethylaniline, a chemical of as yet unknown carcinogenicity. Moreover, CPBS indicated that for the chemicals included in the UKEMS study, highly predictive as well as cost-effective batteries consisting of three short-term assays could be identified.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4-(Dimethylamino)benzonitrile, 98%